Performance of ChatGPT, human radiologists, and context-aware ChatGPT in identifying AO codes from radiology reports

por Russe, Maximilian F., Fink, Anna, Ngo, Helen, Tran, Hien, Bamberg, Fabian, Reisert, Marco, Rau, Alexander
Publicado 2023

Survival of patients with chronic lymphocytic leukemia before and after the introduction of chemoimmunotherapy in Germany

por Kajüter, Hiltraud, Wellmann, Ina, Khil, Laura, Jöckel, Karl-Heinz, Zhang, Can, Fink, Anna-Maria, Hallek, Michael, Stang, Andreas
Publicado 2021

Treatment with idelalisib in patients with chronic lymphocytic leukemia – real world data from the registry of the German CLL Study Group

por von Tresckow, Julia, Heyl, Nikola, Robrecht, Sandra, Giza, Adam, Aldaoud, Ali, Schlag, Rudolf, Klausmann, Martine, Linde, Hartmut, Stein, Wolfgang, Schwarzer, Andreas, Fischer, Kirsten, Cramer, Paula, Eichhorst, Barbara, Hallek, Michael, Fink, Anna Maria
Publicado 2023

Obinutuzumab in Allogeneic Transplantation for CLL and Richter’s Transformation in the Age of Targeted Therapies

por Pflug, Natali, Chakupurakal, Geothy, Fink, Anna-Maria, Robrecht, Sandra, Herling, Marco, Cramer, Paula, Holtick, Udo, Theurich, Sebastian, Schetelig, Johannes, Fischer, Kirsten, Ritgen, Matthias, Scheid, Christof, Eichhorst, Barbara, Dreger, Peter, Hallek, Michael, von Bergwelt-Baildon, Michael
Publicado 2021

SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemia

por Mellinghoff, Sibylle C., Robrecht, Sandra, Mayer, Leonie, Weskamm, Leonie M., Dahlke, Christine, Gruell, Henning, Vanshylla, Kanika, Schlösser, Hans A., Thelen, Martin, Fink, Anna-Maria, Fischer, Kirsten, Klein, Florian, Addo, Marylyn M., Eichhorst, Barbara, Hallek, Michael, Langerbeins, Petra
Publicado 2021

SARS-CoV-2-specific cellular response following third COVID-19 vaccination in patients with chronic lymphocytic leukemia

por Mellinghoff, Sibylle C., Mayer, Leonie, Robrecht, Sandra, Weskamm, Leonie M., Dahlke, Christine, Gruell, Henning, Schlotz, Maike, Vanshylla, Kanika, Schlößer, Hans A., Thelen, Martin, Fink, AnnaMaria, Fischer, Kirsten, Klein, Florian, Addo, Marylyn M., Eichhorst, Barbara, Hallek, Michael, Langerbeins, Petra
Publicado 2022

Sequential treatment with bendamustine, obinutuzumab (GA101) and Ibrutinib in chronic lymphocytic leukemia (CLL): final results of the CLL2-BIG trial

por von Tresckow, Julia, Cramer, Paula, Robrecht, Sandra, Langerbeins, Petra, Fink, Anna-Maria, Al-Sawaf, Othman, Fürstenau, Moritz, Illmer, Thomas, Klaproth, Holger, Tausch, Eugen, Ritgen, Matthias, Fischer, Kirsten, Wendtner, Clemens-Martin, Kreuzer, Karl-Anton, Stilgenbauer, Stephan, Böttcher, Sebastian, Eichhorst, Barbara F., Hallek, Michael
Publicado 2022

P622: GENETIC MARKERS AND OUTCOME OF CLL PATIENTS IN COMBINED TIME-LIMITED TREATMENT WITH ANTI-CD20 ANTIBODY + IBRUTINIB, IDELALISIB OR VENETOCLAX IN THE GCLLSG CLL2-BAG, -BCG, -BI...

por Yosifov, Deyan, von Tresckow, Julia, Giza, Adam, Robrecht, Sandra, Schneider, Christof, Jebaraj, Billy, Mertens, Daniel, Ritgen, Matthias, Schilhabel, Anke, Kreuzer, Karl-Anton, Maria Fink, Anna, Al-Sawaf, Othman, Langerbeins, Petra, Fischer, Kirsten, Eichhorst, Barbara, Hallek, Michael, Döhner, Hartmut, Stilgenbauer, Stephan, Cramer, Paula, Tausch, Eugen
Publicado 2023

Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia

por Kutsch, Nadine, Pallasch, Christian, Tausch, Eugen, Böhme, Volkmar, Ritgen, Matthias, Liersch, Rüdiger, Wacker, Alexander, Jacobs, Georg, Trappe, Ralf Ulrich, Dreger, Peter, Fischer, Kirsten, Fink, Anna-Maria, Stilgenbauer, Stephan, Zhai, Shuyan, Li, Biao, Jürgensmeier, Juliane M., Rajakumaraswamy, Nishanthan, Bhargava, Pankaj, Hallek, Michael, Eichhorst, Barbara F.
Publicado 2022

Efficacy and Safety of Tirabrutinib and Idelalisib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia

por Kutsch, Nadine, Pallasch, Christian, Decker, Thomas, Hebart, Holger, Chow, Kai Uwe, Graeven, Ullrich, Kisro, Jens, Kroeber, Alexander, Tausch, Eugen, Fischer, Kirsten, Fink, Anna-Maria, Wendtner, Clemens-Martin, Ritgen, Matthias, Stilgenbauer, Stephan, Zhang, Danjie, Li, Biao, Jürgensmeier, Juliane M., Rajakumaraswamy, Nishanthan, Bhargava, Pankaj, Hallek, Michael, Eichhorst, Barbara
Publicado 2022

Minimal Residual Disease Dynamics after Venetoclax-Obinutuzumab Treatment: Extended Off-Treatment Follow-up From the Randomized CLL14 Study

por Al-Sawaf, Othman, Zhang, Can, Lu, Tong, Liao, Michael Z., Panchal, Anesh, Robrecht, Sandra, Ching, Travers, Tandon, Maneesh, Fink, Anna-Maria, Tausch, Eugen, Schneider, Christof, Ritgen, Matthias, Böttcher, Sebastian, Kreuzer, Karl-Anton, Chyla, Brenda, Miles, Dale, Wendtner, Clemens-Martin, Eichhorst, Barbara, Stilgenbauer, Stephan, Jiang, Yanwen, Hallek, Michael, Fischer, Kirsten
Publicado 2021

S145: VENETOCLAX-OBINUTUZUMAB FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA: 6-YEAR RESULTS OF THE RANDOMIZED CLL14 STUDY

por Al-Sawaf, Othman, Robrecht, Sandra, Zhang, Can, Olivieri, Stefano, Chang, Yi Meng, Fink, Anna-Maria, Tausch, Eugen, Schneider, Christof, Ritgen, Matthias, Kreuzer, Karl-Anton, Sivcheva, Liliya, Niemann, Carsten, Schwarer, Anthony, Loscertales Pueyo, Javier, Weinkove, Robert, Strumberg, Dirk, Kilfoyle, Allanah, Runkel, Eva, Eichhorst, Barbara, Stilgenbauer, Stephan, Jiang, Yanwen, Hallek, Michael, Fischer, Kirsten
Publicado 2023

P630: SAFETY AND TREATMENT ADHERENCE WITH ACALABRUTINIB IN VERY OLD (≥80Y) AND/OR FRAIL PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) - INTERIM SAFETY ANALYSIS OF THE ONGOING PH...

por Simon, Florian, Ligtvoet, Rudy, Noesslinger, Thomas, Bohn, Jan-Paul, Von Tresckow, Julia, Liersch, Rüdiger, Gaska, Tobias, Jentsch-Ullrich, Kathleen, Koenigsmann, Michael, Wolff, Thomas, Schwaner, Ingo, Wolf, Dominik, Schneider, Christof, Tausch, Eugen, Stilgenbauer, Stephan, Kreuzer, Karl-Anton, Robrecht, Sandra, Fink, Anna-Maria, Fürstenau, Moritz, Fischer, Kirsten, Goede, Valentin, Hallek, Michael, Eichhorst, Barbara
Publicado 2023

S200: IBRUTINIB VERSUS PLACEBO IN PATIENTS WITH ASYMPTOMATIC, TREATMENT-NAÏVE EARLY STAGE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): FINAL RESULTS OF THE PHASE 3, DOUBLE-BLIND, PLACEBO-CO...

por Langerbeins, Petra, Robrecht, Sandra, Nieper, Pascal, Cramer, Paula, Fürstenau, Moritz, Al-Sawaf, Othman, Fink, Anna-Maria, Kreuzer, Karl-Anton, Vehling-Kaiser, Ursula, Tausch, Eugen, Schneider, Christof, Müller, Lothar, Eckart, Michael, Schlag, Rudolf, Freier, Werner, Gaska, Tobias, Balser, Christina, Reiser, Marcel, Stauch, Martina, Wendtner, Clemens, Fischer, Kirsten, Stilgenbauer, Stephan, Eichhorst, Barbara, Hallek, Michael
Publicado 2023

Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia

por Al-Sawaf, Othman, Zhang, Can, Jin, Hyun Yong, Robrecht, Sandra, Choi, Yoonha, Balasubramanian, Sandhya, Kotak, Alex, Chang, Yi Meng, Fink, Anna Maria, Tausch, Eugen, Schneider, Christof, Ritgen, Matthias, Kreuzer, Karl-Anton, Chyla, Brenda, Paulson, Joseph N., Pallasch, Christian P., Frenzel, Lukas P., Peifer, Martin, Eichhorst, Barbara, Stilgenbauer, Stephan, Jiang, Yanwen, Hallek, Michael, Fischer, Kirsten
Publicado 2023

Author Correction: Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymph...

por Al-Sawaf, Othman, Zhang, Can, Jin, Hyun Yong, Robrecht, Sandra, Choi, Yoonha, Balasubramanian, Sandhya, Kotak, Alex, Chang, Yi Meng, Fink, Anna Maria, Tausch, Eugen, Schneider, Christof, Ritgen, Matthias, Kreuzer, Karl-Anton, Chyla, Brenda, Paulson, Joseph N., Pallasch, Christian P., Frenzel, Lukas P., Peifer, Martin, Eichhorst, Barbara, Stilgenbauer, Stephan, Jiang, Yanwen, Hallek, Michael, Fischer, Kirsten
Publicado 2023

COVID-19 among fit patients with CLL treated with venetoclax-based combinations

por Fürstenau, Moritz, Langerbeins, Petra, De Silva, Nisha, Fink, Anna Maria, Robrecht, Sandra, von Tresckow, Julia, Simon, Florian, Hohloch, Karin, Droogendijk, Jolanda, van der Klift, Marjolein, van der Spek, Ellen, Illmer, Thomas, Schöttker, Björn, Fischer, Kirsten, Wendtner, Clemens M., Tausch, Eugen, Stilgenbauer, Stephan, Niemann, Carsten U., Gregor, Michael, Kater, Arnon P., Hallek, Michael, Eichhorst, Barbara
Publicado 2020

Bendamustine followed by ofatumumab and ibrutinib in chronic lymphocytic leukemia: primary endpoint analysis of a multicenter, open-label, phase II trial (CLL2-BIO)

por Cramer, Paula, von Tresckow, Julia, Robrecht, Sandra, Bahlo, Jasmin, Furstenau, Moritz, Langerbeins, Petra, Pflug, Natali, Al-Sawaf, Othman, Heinz, Werner J., Vehling-Kaiser, Ursula, Durig, Jan, Tausch, Eugen, Hensel, Manfred, Sasse, Stephanie, Fink, Anna-Maria, Fischer, Kirsten, Kreuzer, Karl-Anton, Bottcher, Sebastian, Ritgen, Matthias, Kneba, Michael, Wendtner, Clemens-Martin, Stilgenbauer, Stephan, Eichhorst, Barbara, Hallek, Michael
Publicado 2020

Early treatment with FCR versus watch and wait in patients with stage Binet A high-risk chronic lymphocytic leukemia (CLL): a randomized phase 3 trial

por Herling, Carmen D., Cymbalista, Florence, Groß-Ophoff-Müller, Carolin, Bahlo, Jasmin, Robrecht, Sandra, Langerbeins, Petra, Fink, Anna-Maria, Al-Sawaf, Othman, Busch, Raymonde, Porcher, Raphael, Cazin, Bruno, Dreyfus, Brigitte, Ibach, Stefan, Leprêtre, Stéphane, Fischer, Kirsten, Kaiser, Florian, Eichhorst, Barbara, Wentner, Clemens-Martin, Hoechstetter, Manuela A., Döhner, Hartmut, Leblond, Veronique, Kneba, Michael, Letestu, Remi, Böttcher, Sebastian, Stilgenbauer, Stephan, Hallek, Michael, Levy, Vincent
Publicado 2020

Long Term Follow-up Data and Health-Related Quality of Life in Frontline Therapy of Fit Patients Treated With FCR Versus BR (CLL10 Trial of the GCLLSG)

por Kutsch, Nadine, Bahlo, Jasmin, Robrecht, Sandra, Franklin, Jeremy, Zhang, Can, Maurer, Christian, De Silva, Nisha, Lange, Elisabeth, Weide, Rudolf, Kiehl, Michael G., Sökler, Martin, Schlag, Rudolf, Vehling-Kaiser, Ursula, Köchling, Georg, Plöger, Christoph, Gregor, Michael, Plesner, Torben, Herling, Marco, Fischer, Kirsten, Döhner, Hartmut, Kneba, Michael, Wendtner, Clemens-Martin, Klapper, Wolfram, Kreuzer, Karl-Anton, Böttcher, Sebastian, Stilgenbauer, Stephan, Fink, Anna Maria, Hallek, Michael, Eichhorst, Barbara
Publicado 2020